Jazz Pharmaceuticals (JAZZ) Other Operating Expenses (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Other Operating Expenses of $122.8 million for Q1 2026, down 62.01% quarter-over-quarter from $323.3 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Other Operating Expenses (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Other Operating Expenses history runs 17 years deep, the most recent figure standing at $122.8 million for Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to $122.8 million; the TTM figure through Mar 2026 stood at $2.0 billion (up 139.66% YoY), while the FY2025 annual figure was $2.1 billion, up 94.44% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $122.8 million, down from $323.3 million in the prior quarter.
- The five-year high for Other Operating Expenses was $1.2 billion in Q2 2025, with the low at $122.8 million in Q1 2026.
- The 5-year median for Other Operating Expenses is $283.4 million (2022), against an average of $364.6 million.
- The sharpest annual moves came in 2023 and 2025: Other Operating Expenses plunged 59.28% in 2023, then surged 346.48% in 2025.
- Jazz Pharmaceuticals' Other Operating Expenses stood at $679.8 million in 2022, then slumped by 59.28% to $276.8 million in 2023, then increased by 3.91% to $287.6 million in 2024, then rose by 12.4% to $323.3 million in 2025, then tumbled by 62.01% to $122.8 million in 2026.
- Business Quant data shows JAZZ's Other Operating Expenses at $122.8 million in Q1 2026, $323.3 million in Q4 2025, and $339.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122.80 Mn |
| Dec 31, 2025 | 323.27 Mn |
| Sep 30, 2025 | 339.75 Mn |
| Jun 30, 2025 | 1.18 Bn |
| Dec 31, 2024 | 287.62 Mn |
| Sep 30, 2024 | 269.07 Mn |
| Jun 30, 2024 | 265.13 Mn |
| Mar 31, 2024 | 261.22 Mn |
| Dec 31, 2023 | 276.80 Mn |
| Sep 30, 2023 | 257.04 Mn |
| Jun 30, 2023 | 249.60 Mn |
| Mar 31, 2023 | 279.43 Mn |
| Dec 31, 2022 | 679.75 Mn |
| Sep 30, 2022 | 408.54 Mn |
| Jun 30, 2022 | 341.81 Mn |
| Mar 31, 2022 | 287.38 Mn |
| Dec 31, 2021 | 293.45 Mn |
| Sep 30, 2021 | 305.03 Mn |
| Jun 30, 2021 | 259.67 Mn |
| Mar 31, 2021 | 108.38 Mn |